Press room ... 1997 archive
The President’s Call for a Special Project
for an AIDS Vaccine
May 21, 1997
San Francisco, CA—Project Inform, one of the nation’s
best known and largest treatment information and research advocacy
groups today described President Clinton’s call for a special
10 year program to develop an AIDS vaccine as both a welcome commitment
and a somewhat hollow political gesture. Ben Cheng, Assistant Director
of Project Inform’s Information and Advocacy Departments,
said, “Everyone is encouraged that the President has given
new attention to the need to develop an AIDS vaccine. But it’s
not clear that setting a target date will in any way influence how
long it takes to solve this difficult scientific challenge. Real
breakthroughs are needed, not just public statements.” Martin
Delaney, Founding Director of Project Inform, elaborated on this
theme: “The biggest obstacle to getting an effective AIDS
vaccine is not a matter of willpower, it is a matter of science.
In this regard, we are no closer to a vaccine today than we were
three or four years ago. Contrary to popular belief, there really
have been no substantial advances in vaccine research recently which
makes this task any more doable today. Rather than celebrate the
call for a new program, we should be asking, why now? Why didn’t
the administration call for such a program the day it took office,
or at least a number of years ago? Little in the science of AIDS
vaccine research has really changed since then.”
At a series of meetings sponsored nearly 4 years ago by Project
Inform and the Harvard AIDS Institute (called the Madison Project)
senior AIDS researchers from throughout the country called for the
creation of special centralized programs like the one now announced
by the Administration. One program proposed then by the scientists
would have focused in a similar way on an AIDS vaccine. The scientists
even recommended that the program be headed by Dr. David Baltimore,
the same leader called upon today by the Administration. That earlier
recommendation, however, was ignored by the administration which
said, at the time, that it wanted instead to focus its efforts on
building up the new Office of AIDS Research and doing its own evaluation
of needs in AIDS research. Three and half years later, that process
resulted in essentially the same recommendations made by the scientists
of the Madison Project. “In my view,” Delaney said,
“the Administration wasted several years creating its own
bureaucracy to make what amounts to an obvious recommendation. But
at least it’s finally going to happen.”
Brenda Lein, Director of Project Inform’s Information and
Advocacy Departments, expressed another concern about the belatedly
proposed vaccine project. “This proposal can only make a difference
if the administration commits substantial new funds to AIDS research.
Without additional funding, it will be little more than a public
relations tool, one that could just as easily have been announced
in 1993. Moreover, it’s critical that funding not come from
other ongoing programs, including prevention research, or adult
and pediatric therapy research. All of these must remain high priorities.”
Asked whether developing a vaccine within 10 years is a reasonable
goal, Ben Cheng commented, “No one really knows how long it
will take. Most estimates suggest that once a good candidate vaccine
is found, it may take as long as 10 years just to prove that it
works. But few scientists today believe that we have any truly promising
vaccine candidates. Fundamental scientific obstacles still lie ahead
of us. Still, if the President is serious and willing to commit
the necessary funds, I’m confident that things will move faster
than they would have otherwise."
.